First hydroxychloroquine randomized controlled trial reads out with a disappointing viral clearance rate of 87% vs 93% control arm.
— GC (@gcbioinv) March 24, 2020
Unfortunately not what we needed right now but hopes that in a more severe population we will see something
H/t Umer Raffat + team @ ISI pic.twitter.com/1qCIhToYLx
from Hacker News https://twitter.com/gcbioinv/status/1242268829906018304
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.